News & Press

Follow our news to learn how Dermagnostix is redefining molecular diagnostics in dermatology with our point-of-need microfluidics platform.

News

Dermagnostix kündigt Übernahme und Fortführung der Fluoreszenzdetektor Technologie von Dialunox zum 01.07.2025 an

Die Dermagnostix GmbH aus Freiburg, spezialisiert auf die Entwicklung molekulardiagnostischer Tests für dermatologische Fragestellungen, erweitert ihr Leistungsportfolio durch die Übernahme und Fortführung der Fluoreszenzdetektor Technologie der Dialunox GmbH i.L. aus Stockach zum 01.07.2025.

May 5, 2025
read more
Dermagnostix kündigt Übernahme und Fortführung der Fluoreszenzdetektor Technologie von Dialunox zum 01.07.2025 an

Dermagnostix announces acquisition and continuation of the fluorescence detector technology of Dialunox as of July 1st 2025

The Dermagnostix GmbH from Freiburg, specialized on the development of molecular diagnostic tests for dermatology, expands its portfolio by the acquisition and continuation of the fluorescence detector technology of Dialunox GmbH i.L. (Stockach) as of July 1st 2025.

May 5, 2025
read more
Dermagnostix announces acquisition and continuation of the fluorescence detector technology of Dialunox as of July 1st 2025

State Parliament President Muhterem Aras and Member of Parliament Nadyne Saint-Cast Visit Dermagnostix in Freiburg

Muhterem Aras and Nadyne Saint-Cast recently visited Dermagnostix. Together with Dermagnostix’ managing directors Natalie Garzorz-Stark and Ludwig Gutzweiler they discussed the challenges and opportunities for healthcare start-ups, highlighting the role of political support for private investments.

March 21, 2025
read more
State Parliament President Muhterem Aras and Member of Parliament Nadyne Saint-Cast Visit Dermagnostix in Freiburg

Dermagnostix at MEDICA 2024

Dermagnostix has been selected by the EIC- International Fairs 3.0 Programme as a startup with groundbreaking innovation for MEDICA 2024 (11.-14. November in Düsseldorf, Germany).

September 4, 2024
read more
Dermagnostix at MEDICA 2024

Dermagnostix on tour in June 2024

June was packed with exciting events and we had a great time exhibiting at ADH annual meeting in Göttingen as well as IFPA conference in Stockholm.

July 18, 2024
read more
Dermagnostix on tour in June 2024

Dermagnostix GmbH announces product launch of PsorX®-LabDisk (CE-IVD) after successful pilot customer phase

Dermagnostix announces the official launch of the PsorX®-LabDisk. After the market entry with CE-IVD certification in 2022 and a following successful pilot customer phase, the innovative molecular test for the differential diagnosis of psoriasis and eczema was officially launched in June 2024.  The Dermagnostix system consisting of the LabDisk-Analyzer, LabDisk and the Connectivity Solution marks

June 13, 2024
read more
Dermagnostix GmbH announces product launch of PsorX®-LabDisk (CE-IVD) after successful pilot customer phase

Next Generation Pathology – Dermagnostix at the DGP Annual Meeting in Munich

“We need this test in our lab!” – it’s hard to imagine a better welcome from a visitor to our booth. Even though we were serving a niche with dermatopathology at the 107th Annual Meeting of the German Society of Pathology (DGP), we were even more pleased about the enthusiasm shown by our booth visitors.

May 28, 2024
read more
Next Generation Pathology – Dermagnostix at the DGP Annual Meeting in Munich


Subscribe to our newsletter!